Catheter Precision, Inc.
A medical device company that develops technology for cardiac electrophysiology, including the VIVO system used to help locate the source of abnormal heart rhythms before procedures. The company's tools are used by doctors in hospitals to guide treatment of conditions like ventricular tachycardia. It was formed through a merger of earlier cardiac-mapping ventures and is based in the United States.
| Holder | Schedule | % of class | Shares | Filed |
|---|---|---|---|---|
| C/M Capital Partners, LP | 13GPassive | 9.99% | 1.60M | Aug 21, 2026 |
| Thomas Walsh | 13GPassive | 9.99% | 1.60M | Aug 21, 2026 |
| Jonathan Juchno | 13GPassive | 9.99% | 1.60M | Aug 21, 2026 |
| C/M Capital Master Fund, LP | 13GPassive | 5.49% | 878.5K | Aug 21, 2026 |
| WVP Emerging Manager Onshore Fund LLC | 13GPassive | 5.49% | 878.5K | Aug 21, 2026 |
| SEG JETS SPV I, LLC | 13GPassive | 9.79% | 1.07M | Jul 20, 2026 |
| Gregory Castaldo | 13GPassive | 7.5% | 176.7K | Feb 11, 2026 |
| Joseph Reda | 13GPassive | 7.5% | 176.7K | Feb 11, 2026 |
| Armistice Capital, LLC | 13G/APassive | 4.99% | 1.12M | Aug 14, 2025 |
| Steven Boyd | 13G/APassive | 4.99% | 1.12M | Aug 14, 2025 |